Shorter light therapy may be just as good for treating bulging corneas

NCT ID NCT07124910

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This phase 3 trial tests whether a shorter 18-minute ultraviolet (UVA) light exposure works as well as the standard 24-minute exposure during corneal crosslinking for keratoconus and similar conditions. The treatment uses riboflavin (vitamin B2) eye drops followed by UVA light to strengthen the cornea and stop vision loss. About 485 participants aged 8 and older will be followed for 6 months to compare changes in corneal shape and eyesight between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
riboflavin (vitamin B2) eye drops plus ultraviolet (UVA) light
What this could lead to
If it works, this could show that a shorter 18-minute UVA exposure is just as effective as the standard 24-minute one, making treatment faster and more comfortable.
What could go wrong
This is still an experimental treatment not yet FDA-approved. The trial is relatively small and only follows participants for 6 months, so long-term benefits and risks are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ECTASIA OF CORNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Woolfson Eye Institute

    RECRUITING

    Atlanta, Georgia, 30328, United States

  • Woolfson Eye Institute

    RECRUITING

    Atlanta, Georgia, 30349, United States

  • Woolfson Eye Institute

    RECRUITING

    Canton, Georgia, 30114, United States

  • Woolfson Eye Institute

    RECRUITING

    Cumming, Georgia, 30041, United States

  • Woolfson Eye Institute

    RECRUITING

    Douglasville, Georgia, 30134, United States

  • Woolfson Eye Institute

    RECRUITING

    Lawrenceville, Georgia, 30043, United States

  • Woolfson Eye Institute

    RECRUITING

    Marietta, Georgia, 30066, United States

  • Woolfson Eye Institute

    RECRUITING

    Snellville, Georgia, 30078, United States

  • Woolfson Eye Institute

    RECRUITING

    Asheville, North Carolina, 28803, United States

  • Woolfson Eye Institute

    RECRUITING

    Chattanooga, Tennessee, 37421, United States

  • Woolfson Eye Institute

    RECRUITING

    Johnson City, Tennessee, 37615, United States

  • Woolfson Eye Institute

    RECRUITING

    Knoxville, Tennessee, 37922, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.